Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1222023.RAValI50oR-Do_KfTernIsNhu-H9ls_QpbEPGVsTrC1m4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1222023.RAValI50oR-Do_KfTernIsNhu-H9ls_QpbEPGVsTrC1m4130_assertion type Assertion NP1222023.RAValI50oR-Do_KfTernIsNhu-H9ls_QpbEPGVsTrC1m4130_head.
- NP1222023.RAValI50oR-Do_KfTernIsNhu-H9ls_QpbEPGVsTrC1m4130_assertion description "[Additional high-resolution studies in multiple vascular beds are required to address the therapeutic potential of NADPH oxidase inhibition in cardiovascular diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1222023.RAValI50oR-Do_KfTernIsNhu-H9ls_QpbEPGVsTrC1m4130_provenance.
- NP1222023.RAValI50oR-Do_KfTernIsNhu-H9ls_QpbEPGVsTrC1m4130_assertion evidence source_evidence_literature NP1222023.RAValI50oR-Do_KfTernIsNhu-H9ls_QpbEPGVsTrC1m4130_provenance.
- NP1222023.RAValI50oR-Do_KfTernIsNhu-H9ls_QpbEPGVsTrC1m4130_assertion SIO_000772 25239440 NP1222023.RAValI50oR-Do_KfTernIsNhu-H9ls_QpbEPGVsTrC1m4130_provenance.
- NP1222023.RAValI50oR-Do_KfTernIsNhu-H9ls_QpbEPGVsTrC1m4130_assertion wasDerivedFrom befree-2016 NP1222023.RAValI50oR-Do_KfTernIsNhu-H9ls_QpbEPGVsTrC1m4130_provenance.
- NP1222023.RAValI50oR-Do_KfTernIsNhu-H9ls_QpbEPGVsTrC1m4130_assertion wasGeneratedBy ECO_0000203 NP1222023.RAValI50oR-Do_KfTernIsNhu-H9ls_QpbEPGVsTrC1m4130_provenance.